Presentation Theater #1: VASCEPA® (icosapent ethyl): Elevating the Standard of Care


There is an urgency to treat Persistent Cardiovascular Risk (P-CVR) as it remains high despite statin-based standard-of-care therapy in patients with elevated triglycerides. In this program, we will review data from a practice changing trial that provides a new therapeutic option to elevate the current standard of care.

Speaker: Daniel Hilleman, PharmD

Presented by Amarin

Interest: Presentation Theater
Session Time Slot(s): 
Saturday, March 21
1:30 PM - 2:30 PM
Gaylord National - Prince George's Exhibit Hall